AtriCure, Inc.

NASDAQ (USD): AtriCure, Inc. (ATRC)

Last Price

23.19

Today's Change

+0.73 (3.25%)

Day's Change

22.06 - 23.52

Trading Volume

922,032

Overview

Market Cap

1 Billion

Shares Outstanding

48 Million

Avg Volume

787,084

Avg Price (50 Days)

25.13

Avg Price (200 Days)

34.98

PE Ratio

-28.99

EPS

-0.80

Earnings Announcement

23-Jul-2024

Previous Close

22.46

Open

22.45

Day's Range

22.06 - 23.52

Year Range

20.19 - 59.61

Trading Volume

922,032

Price Change Highlight

1 Day Change

3.25%

5 Day Change

3.80%

1 Month Change

0.09%

3 Month Change

-32.17%

6 Month Change

-44.79%

Ytd Change

-34.34%

1 Year Change

-49.27%

3 Year Change

-68.50%

5 Year Change

-22.29%

10 Year Change

45.67%

Max Change

64.70%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Instruments & Supplies

Description:

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment